Daily1 天
Phase 3 Trial Confirms Nemolizumab’s Efficacy for Moderate to Severe Prurigo Nodularis
In the phase 3 trial, nemolizumab monotherapy showed rapid and sustained improvements in key signs (skin lesions) and ...